If you or a loved one has suffered from eye damage caused by Elmiron, you may be eligible for a lawsuit. This medication, manufactured by Janssen Pharmaceuticals, is linked to an increased risk of developing maculopathy, a progressive eye disease. This condition can eventually cause blindness, although it can be prevented through proper early detection and treatment. An attorney specializing in eye injury claims can investigate your claim and make recommendations about the best course of action, including multi-district litigation and individual cases. They can even bring in experts if necessary.
Maculopathy
If you have suffered from vision problems after taking Elmiron, you may be able to file an Elmiron eye damage lawsuit. This type of lawsuit is relatively new, and it may take a few years to resolve. In order to be successful, you must submit a detailed claim that includes all medical records related to your condition. The more severe your injury is, the more compensation you will likely receive.
In the past month, however, the pace of new Elmiron eye damage lawsuits has slowed, with 15 cases filed over the past 30 days. The total number of pending cases in the Elmiron MDL is now over 1,700. This is the largest increase since the MDL was created and the largest percentage increase of any mass tort over the same period. The pace of new cases is likely to increase over the next five months, as bellwether trials begin in January.
Dangerous side effects of Elmiron
Elmiron is a medicine that breaks down blood clots in the body. This drug can cause a number of side effects, including severe hair loss. It is also associated with a rash, and patients should contact their doctor if they notice this side effect. Other possible side effects of Elmiron include nausea, diarrhea, and stomach issues. While most side effects of Elmiron are temporary, some are permanent and can cause serious health problems.
Elmiron is an anticoagulant used to treat interstitial cystitis, a condition that affects more women than men. This medication can interfere with the nerves that send messages from the brain to the bladder, resulting in the inability to urinate. While it is not a cure for this disease, it does help relieve pain and restore damaged bladder surfaces. While Elmiron can cause dangerous side effects, most people tolerate it well. In clinical trials, it has been shown that about 1 to 4% of patients develop side effects. Of these, 33 people developed serious side effects and six patients died.
Failure to warn of dangers
If you or someone you know has been injured by Elmiron, you may be eligible to file a lawsuit. Elmiron eye damage lawsuits focus on the manufacturer's failure to warn about the risks of this drug. Although Janssen knew that Elmiron was a risky drug, it did not warn consumers or physicians of the risks. Moreover, it did not take Elmiron off the market when it became obvious that the risks outweighed the benefits.
Janssen Pharmaceuticals did not adequately warn consumers of the potential dangers of Elmiron, and as a result, hundreds of thousands of people have been exposed to the side effects. While the drug does not carry a warning label, many studies have confirmed that the drug can cause serious eye problems, including macular degeneration and blindness. As a result, the drug's manufacturers are liable for the injuries of affected patients.
Class action lawsuits
Thousands of Elmiron eye damage class action lawsuits are pending in federal and state courts around the country. These lawsuits are brought by patients who have suffered vision problems from Elmiron. These cases are being actively filed as people are questioning the proper prescription for the drug and who is eligible for financial compensation. We spoke to Jerry Parker, a partner at the law firm Parker Waichman LLP, to learn about the lawsuits and answer some of your questions.
The lawsuits allege that Elmiron caused avoidable vision loss and retinal pigmentary degeneration in a number of patients. Janssen Pharmaceuticals is accused of knowing about these risks, but failed to make any changes in the drug or its packaging, instructions or warnings. These companies have also failed to properly screen the product for these side effects, which may lead to adverse effects. If you think you might be a victim of eye damage from Elmiron, talk to your attorney to determine if you're eligible for a lawsuit.
Settlement amounts
Although the number of new Elmiron lawsuits has been slowing down over the past month, there are still about 1,700 Elmiron eye damage claims pending in federal class action litigation and more than 170 in New Jersey state courts. The Elmiron eye injury lawsuit has been named a bellwether case, which means that the verdict and settlement amounts will be closely monitored by other plaintiffs. A large Elmiron verdict will draw attention to the company, and could signal to juries that their product is a dangerous one.
The company that manufactures Elmiron, which is used to treat interstitial cystitis, has been criticized for failing to warn users of the adverse side effects of this medication. The company, which is based in Belgium, failed to warn patients about the potential risk of eye damage from the drug. Additionally, it failed to carry out further research into the potential side effects of the medication.
0
Sign in to leave a comment.